Non-high-density lipoprotein cholesterol versus low-density lipoprotein cholesterol as a risk factor for a first nonfatal myocardial infarction

被引:45
作者
Farwell, WR
Sesso, HD [1 ]
Buring, JE
Gaziano, JM
机构
[1] Brigham & Womens Hosp, Vet Affairs Med Ctr, Dept Med, Div Aging, Boston, MA 02115 USA
[2] Brigham & Womens Hosp, Vet Affairs Med Ctr, Dept Med, Div Prevent Med, Boston, MA 02115 USA
[3] Brigham & Womens Hosp, Vet Affairs Med Ctr, Dept Med, Div Cardiovasc, Boston, MA 02115 USA
[4] Harvard Univ, Sch Med, Boston, MA 02115 USA
[5] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA
[6] Harvard Univ, Sch Med, Dept Ambulatorio Care & Prevent, Boston, MA 02115 USA
关键词
D O I
10.1016/j.amjcard.2005.06.044
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Low-density lipoprotein (LDL) cholesterol is the primary lipid parameter targeted to prevent myocardial infarction. Alternatively, non-high-density lipoprotein (HDL) cholesterol includes LDL cholesterol and other atherogenic particles but does not require a fasting sample. Non-HDL cholesterol and LDL cholesterol as predictors of first nonfatal myocardial infarction were compared in 303 patients and 297 controls matched for age, gender, and community within the Boston Area Health Study. Patients were white men or women aged <76 years living in the Boston area, without a history of myocardial infarction or angina pectoris, in whom symptoms of confirmed myocardial infarction began during the 24 hours before admission. After multivariate adjustment for coronary risk factors in unmatched analyses, the corresponding odds ratios (ORs) of a first nonfatal myocardial infarction for non-HDL cholesterol in the second, third, and fourth quartiles were 1.83 (95% confidence interval [CI] 1.07 to 3.14), 2.07 (95% CI 1.23 to 3.49), and 2.33 (95% CI 1.39 to 3.90) (p trend <0.01). For LDL cholesterol, the ORs were 1.10 (95% CI 0.67 to 1.81), 0.87 (95% CI 0.52 to 1.46), and 1.45 (95% CI 0.90 to 2.35) (p trend = 0.16). Including HDL cholesterol in the model increased the ORs and strengthened the test for a trend for LDL cholesterol, whereas the ORs were decreased and the test for a trend was weakened for non-HDL cholesterol. In conclusion, given that non-HDL cholesterol accounts for LDL cholesterol plus other atherogenic particles but does not require a fasting sample, this study suggests that non-HDL cholesterol may be at least as useful as LDL cholesterol to initially screen patients for risk of a first nonfatal myocardial infarction. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:1129 / 1134
页数:6
相关论文
共 27 条
  • [1] [Anonymous], 1982, CASE CONTROL STUDIES
  • [2] Hypertriglyceridemia and elevated lipoprotein(a) are risk factors for major coronary events in middle-aged men
    Assmann, G
    Schulte, H
    vonEckardstein, A
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1996, 77 (14) : 1179 - 1184
  • [3] Non-high-density lipoprotein cholesterol levels predict five-year outcome in the Bypass Angioplasty Revascularization Investigation (BARI)
    Bittner, V
    Hardison, R
    Kelsey, SF
    Weiner, BH
    Jacobs, AK
    Sopko, G
    [J]. CIRCULATION, 2002, 106 (20) : 2537 - 2542
  • [4] EPIDEMIOLOGY OF TRIGLYCERIDES - A VIEW FROM FRAMINGHAM
    CASTELLI, WP
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1992, 70 (19) : H3 - H9
  • [5] Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
    Cleeman, JI
    Grundy, SM
    Becker, D
    Clark, LT
    Cooper, RS
    Denke, MA
    Howard, WJ
    Hunninghake, DB
    Illingworth, DR
    Luepker, RV
    McBride, P
    McKenney, JM
    Pasternak, RC
    Stone, NJ
    Van Horn, L
    Brewer, HB
    Ernst, ND
    Gordon, D
    Levy, D
    Rifkind, B
    Rossouw, JE
    Savage, P
    Haffner, SM
    Orloff, DG
    Proschan, MA
    Schwartz, JS
    Sempos, CT
    Shero, ST
    Murray, EZ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19): : 2486 - 2497
  • [6] Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality
    Cui, YD
    Blumenthal, RS
    Flaws, JA
    Whiteman, MK
    Langenberg, P
    Bachorik, PS
    Bush, TL
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2001, 161 (11) : 1413 - 1419
  • [7] FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
  • [8] Serum lipids and incidence of coronary heart disease - Findings from the systolic hypertension in the elderly program (SHEP)
    Frost, PH
    Davis, BR
    Burlando, AJ
    Curb, JD
    Guthrie, GP
    Isaacsohn, JL
    WassertheilSmoller, S
    Wilson, AC
    Stamler, J
    [J]. CIRCULATION, 1996, 94 (10) : 2381 - 2388
  • [9] Fasting triglycerides, high-density lipoprotein, and risk of myocardial infarction
    Gaziano, JM
    Hennekens, CH
    ODonnell, CJ
    Breslow, JL
    Buring, JE
    [J]. CIRCULATION, 1997, 96 (08) : 2520 - 2525
  • [10] GIOVANNUCCI E, 1991, AM J EPIDEMIOL, V133, P810